Q-Linea
Infection diagnostics company developing rapid AST solutions for sepsis.
QLINEA | ST
Overview
Corporate Details
- ISIN(s):
- SE0011527845 (+2 more)
- LEI:
- 549300BXVB4XRM8WSC73
- Country:
- Sweden
- Address:
- Dag Hammarskjölds väg 52A, 752 37 Uppsala
- Website:
- https://www.qlinea.com/
- Sector:
- Manufacturing
Description
Q-Linea is an infection diagnostics company that develops and manufactures solutions for infectious diseases, with a primary focus on sepsis. The company's core product is the ASTar instrument, a fully automated, benchtop system that provides rapid phenotypic antimicrobial susceptibility testing (AST) directly from positive blood cultures. The ASTar system is designed to significantly reduce the time to result compared to traditional diagnostic methods, which can take up to 48 hours. By delivering faster results, the technology enables clinicians to make earlier, more informed decisions on appropriate antibiotic treatments for critically ill patients. This capability aims to improve patient outcomes, support antibiotic stewardship, and help combat the development of antimicrobial resistance.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-28 08:58 |
Technology behind Podler valued at SEK 70 million
|
English | 52.5 KB | ||
| 2024-05-27 11:45 |
Ändrat datum för kvartalsrapport
|
Swedish | 40.9 KB | ||
| 2024-05-27 11:45 |
Changed date for Interim Report
|
English | 40.9 KB | ||
| 2024-05-15 11:45 |
Changed dates for Interim Report and Annual General Meeting
|
English | 41.5 KB | ||
| 2024-05-15 11:45 |
Ändrade datum för kvartalsrapport och årsstämma
|
Swedish | 41.4 KB | ||
| 2024-04-26 15:40 |
Q-linea receives US FDA 510(k) clearance for the ASTar® System
|
English | 51.9 KB | ||
| 2024-04-26 15:40 |
Q-linea får FDA 510(k)-godkännande för ASTar®
|
Swedish | 51.9 KB | ||
| 2024-04-12 08:00 | Swedish | 26.7 MB | |||
| 2024-04-12 08:00 | Swedish | 26.7 MB | |||
| 2024-02-27 07:30 | Swedish | 587.5 KB | |||
| 2024-02-27 07:30 | English | 581.3 KB | |||
| 2024-02-01 10:00 |
Anders Ljunggren takes office as Managing Director of Q-linea AB on 1 March 2024
|
English | 51.9 KB | ||
| 2024-02-01 10:00 |
Anders Ljunggren tillträder som vd för Q-linea AB den 1 mars 2024
|
Swedish | 51.4 KB | ||
| 2024-01-30 10:00 |
Q-linea initierar kostnadsbesparingsprogram
|
Swedish | 53.7 KB | ||
| 2024-01-30 10:00 |
Q-linea initiates cost savings program
|
English | 52.9 KB |
Automate Your Workflow. Get a real-time feed of all Q-Linea filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Q-Linea
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Q-Linea via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-21 | James Kathrein | Other | Other | 5,692,547 | 170,776.41 SEK |
| 2025-05-21 | Stuart Gander | Other | Other | 5,000,000 | 150,000.00 SEK |
| 2025-05-19 | Erika Kjellberg Eriksson | Other | Other | 5,000,000 | 150,000.00 SEK |
| 2025-05-19 | Erika Kjellberg Eriksson | Other | Other | 3,234,000 | 97,020.00 SEK |
| 2023-08-03 | Nexttobe AB | Other | Buy | 23,132,612 | 69,397,836.00 SEK |
| 2023-07-21 | Christer Samuelsson | Other | Other | 30,000 | 90,000.00 SEK |
| 2023-03-14 | Christer Samuelsson | Other | Buy | 16,000 | 141,731.01 SEK |
| 2023-03-13 | Christer Samuelsson | Other | Buy | 4,000 | 41,398.00 SEK |
| 2023-02-28 | Jonas Jarvius | Other | Buy | 41,646 | 437,283.00 SEK |
| 2023-02-28 | CFO Akuten AB | Other | Buy | 10,761 | 112,955.62 SEK |
Peer Companies
